R 
Regenerative Medical Technology Group RMTG · USD
Consumer Discretionary · US listing · 🇺🇸 United States
0.03
0.00%
Close of 5 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$5.1m
FY2016FY2025
Net income
−$7.8m
FY2016FY2025
Free cash flow
−$1.3m
FY2016FY2025
Shareholders' equity
−$34.7m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1m | $4.1m | $2.4m | $1.5m | $437,887 | $55,082 | $30,000 | $50,116 | $29,241 | — |
| Operating income | −$867,162 | $81,181 | −$715,230 | −$1.2m | −$9.9m | −$448,420 | −$1.6m | −$255,193 | −$500,642 | −$451,052 |
| Net income | −$7.8m | −$5.6m | −$9.8m | −$5.5m | −$12.9m | −$5.9m | −$2.5m | −$2.1m | −$377,007 | −$4.2m |
| Diluted earnings per share | -0.59 | -0.44 | -0.79 | -0.45 | -1.07 | -0.59 | -0.47 | -0.52 | -0.10 | -2.11 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $4.5m | $3.8m | $2.9m | $8.1m | $9.3m | $219,734 | $30,000 | $34,634 | $7,859 | $15,200 |
| Cash and short-term investments | $956,718 | $1.2m | $530,540 | $1.6m | $3.0m | $42,534 | $20,000 | $30,834 | $7,750 | $6,648 |
| Total liabilities | $39.2m | $31.2m | $24.7m | $20.1m | $16.1m | $6.6m | $7.3m | $4.6m | $2.6m | $5.5m |
| Debt | $19.6m | $20.0m | $17.7m | $15.1m | $13.4m | $5.8m | $1.6m | $812,827 | $378,013 | $432,884 |
| Shareholders' equity | −$34.7m | −$27.4m | −$21.8m | −$12.0m | −$6.8m | −$6.4m | −$7.3m | −$4.5m | −$2.6m | −$5.5m |
| Shares outstanding | 13m | 13m | 12m | 12m | 12m | 10m | 5m | 4m | 4m | 2m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$706,519 | $850,699 | −$419,200 | −$1.1m | −$9.9m | −$322,745 | −$360,000 | −$244,640 | −$6,116 | −$380,925 |
| Capital spending | −$602,583 | −$215,419 | −$385,596 | −$198,428 | −$4 | −$5 | — | −$4,000 | −$4 | — |
| Free cash flow | −$1.3m | $635,280 | −$804,796 | −$1.3m | −$9.9m | −$322,750 | −$360,000 | −$248,640 | −$6,120 | −$380,925 |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0m | $2.6m | $1.6m | $1.2m | $983,518 | $1.4m | $1.5m | $986,308 |
| Operating income | $565,977 | $229,783 | −$306,274 | −$445,761 | −$250,086 | $134,960 | $380,618 | $106,145 |
| Net income | −$2.9m | −$876,274 | −$1.4m | −$4.4m | −$1.3m | −$760,040 | −$638,185 | −$887,146 |
| Diluted earnings per share | -0.22 | -0.07 | -0.11 | -0.33 | -0.10 | -0.06 | -0.05 | -0.07 |
| Total assets | $5.9m | $5.0m | $4.5m | $4.5m | $4.5m | $4.0m | $3.8m | $3.2m |
| Cash and short-term investments | $1.3m | $1.1m | — | $1.2m | $1.6m | $1.2m | — | $836,427 |
| Debt | $21.2m | $20.2m | $2.0m | $18.3m | $20.6m | $19.8m | $2.0m | $19.8m |
| Shareholders' equity | −$39.3m | −$35.6m | −$34.7m | −$30.1m | −$29.0m | −$28.1m | −$27.4m | −$26.7m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 49.4% | 147.4% | 98.3% |
| Operating income | -9.9% | 14.1% | 3.7% |
| Net income | 12.5% | 5.8% | 15.0% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -8.5% | -20.4% | -95.8% | — |
| Net margin | -145.3% | -218.2% | -347.9% | — |
Valuation history
At each fiscal year end
| FY2025 | |
|---|---|
| Price to earnings | -0.1 |
| Price to sales | 0.1 |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 9367% | 1318% | 976% | -55% | 241% | 22931% | 1802% | 12671264% | 21233% | 11% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 1000-to-1 reverse split · 26 Sept 2018
- 600-to-1 reverse split · 12 Nov 2014
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.